Osteopontin can act as an effector for a germline mutation of BRCA1 in malignant transformation of breast cancer-related cells. [electronic resource]
Producer: 20100914Description: 1354-60 p. digitalISSN:- 1349-7006
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.